Since the IGF/IGF-1R signaling pathway is a target of cancer therapies, investigation into the associations between the tumor microenvironment and IGF/IGF-1R signaling may aid in the development of therapeutic strategies [122]. The gene discussed is IGF1; the disease is cancer.